BridgeMD
New treatment option for Arrhythmogenic Right Ventricular Cardiomyopathy
Official title FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))
ClinicalTrials.gov ID: NCT07563660
What this study is testing
- What it's testing
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease associated with fibrofatty myocardial replacement, ventricular arrhythmias, and an increased risk of sudden cardiac death. Although current diagnostic approaches, including the 2010 Task Force Criteria and the Padua criteria, improve recognition of the disease, early diagnosis remains challenging, particularly when structural abnormalities are subtle or absent on conventional imaging.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older
- Established diagnosis of arrhythmogenic right ventricular cardiomyopathy according to the 2010 Revised Task Force Criteria and/or the Padua criteria
- Under active follow-up at the study center
- Ability to understand the study procedures and provide written informed consent
You likely can't join if
- History of malignancy
- Severe renal impairment
- Severe hepatic impairment
- Pregnancy or breastfeeding
- Prior 68Ga-DOTA-SA-FAPI PET/CT imaging
- Inability or unwillingness to provide written informed consent
See the full eligibility criteria
- Adults aged 18 years or older
- Established diagnosis of arrhythmogenic right ventricular cardiomyopathy according to the 2010 Revised Task Force Criteria and/or the Padua criteria
- Under active follow-up at the study center
- Ability to understand the study procedures and provide written informed consent
- History of malignancy
- Severe renal impairment
- Severe hepatic impairment
- Pregnancy or breastfeeding
- Prior 68Ga-DOTA-SA-FAPI PET/CT imaging
- Inability or unwillingness to provide written informed consent
- Any medical, clinical, or logistical condition that, in the opinion of the investigators, could interfere with study participation, image interpretation, or completion of follow-up
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Fatih, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Fatih, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.